NCT00539448 - Gulf, Lantus, Apidra Evaluation in Type 1 Diabetics Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG

insulin glargine

in combination with insulin Glulisine as bolus regimen

DRUG

insulin glulisine

in combination with insulin Glargine as bolus regimen

Trial Locations (4)

Sanofi-aventis administrative office, Manama

Sanofi-aventis administrative office, Kuwait City

Sanofi-Aventis Administrative Office, Doha

Sanofi-aventis administrative office, Dubai